Accepted for/Published in: JMIR Formative Research
Date Submitted: Feb 7, 2023
Date Accepted: Jun 14, 2023
Effectiveness of an internet-based self-guided program to treat depression in a sample of Brazilian users: results of a randomized controlled trial
ABSTRACT
Background:
Depression is undertreated in Brazil. Deprexis is an internet-based program to treat depressive symptoms based on empirically supported integrative and cognitive-behavioral therapy. Evidence from metanalysis supports Deprexis’ efficacy in German-speaking countries and the United States of America, but no study has yet been conducted using this program in countries with low literacy rates and large social disparities. Furthermore, few studies have investigated whether internet-based interventions ameliorate psychological processes that might underlie depressive symptomatology, such as low perceived self-efficacy.
Objective:
To evaluate the effectiveness of the Brazilian-Portuguese version of Deprexis in a sample of Brazilian adults with elevated depressive symptoms.
Methods:
We randomized 189 moderately to severely depressed participants to an intervention condition (treatment as usual [TAU] plus immediate access to Deprexis for 90 days, n=94), or to a control condition (TAU and delayed access to Deprexis, after 8 weeks, n=95).
Results:
Intention-to-treat analysis using a linear mixed model showed that participants who received Deprexis improved significantly more than participants assigned to the delayed access control group on the primary depression measure (Cohen's d=0.80), and secondary outcomes such as general psychological state measure (d=0.82), and the perceived self-efficacy measure (d=0.63). ITT analyses show that 21.3% of the participants achieved remission against 7.4% in the control group (p < 0.001). Participants reported a medium to high level of satisfaction with Deprexis.
Conclusions:
These results replicate previous findings by showing that Deprexis can facilitate symptomatic improvement over 3 months for a depressed sample of Brazilian users. It extends previous research by showing significant effects on perceived self-efficacy. Clinical Trial: ReBec RBR-6kk3bx, UTN U1111-1212-8998
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.